Related Experiment Video
Updated: Jan 8, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Triage Temperature and Timeliness of Sepsis Interventions in a Pediatric Emergency Department
McKenna Straus1, John M Morrison1,2, Racha Khalaf3
1Johns Hopkins All Children's Hospital, Office of Medical Education, St. Petersburg, Florida.
Insights
Children with sepsis presenting with hypothermia (temperature ≤ 36.0 °C) had worse outcomes, including increased mortality and organ dysfunction. However, temperature at the physiologic onset of sepsis (PO-S) did not affect the time to antibiotic or fluid bolus administration.
Area of Science:
- Pediatric Emergency Medicine
- Infectious Disease
- Critical Care Medicine
Background:
- Fever often signals infection, prompting sepsis evaluation in emergency departments (ED).
- In adults, normal temperature during sepsis presentation correlates with delayed treatment and higher mortality.
- The relationship between temperature and sepsis care timeliness in pediatric EDs is not well understood.
Purpose of the Study:
- To investigate the association between body temperature at the physiologic onset of sepsis (PO-S) and the time to antibiotic and fluid bolus administration in children.
- To identify if temperature at PO-S impacts key pediatric sepsis outcomes.
Main Methods:
- Retrospective cohort study of pediatric sepsis patients in the ED.
- Assessed body temperature at PO-S, defined as the first time clinical sepsis criteria were met.
- Analyzed time to antibiotics/fluids, mortality, organ dysfunction, and ICU/hospital-free days using multivariable quantile regression.
Main Results:
- No significant difference in median time to antibiotic or fluid bolus administration was found across temperature groups (hypothermia, normothermia, fever).
- Children with hypothermia (≤ 36.0 °C) at PO-S showed significantly higher mortality (4.5%) and organ dysfunction at 72 hours (68.2%).
- Hypothermic children also experienced fewer ICU- and hospital-free days compared to normothermic or febrile children.
Conclusions:
- Body temperature at PO-S did not influence the timeliness of antibiotic or fluid bolus delivery in pediatric sepsis.
- Pediatric sepsis patients presenting with hypothermia face poorer clinical outcomes, including increased mortality and organ dysfunction.
Introduction:
Fever as an indicator of infection is frequently used as an aid in triggering concern for sepsis in the emergency department (ED). Adults with sepsis presenting to the ED with a normal temperature have been shown to have delays in treatment and greater mortality. The association between temperature and timeliness of sepsis-related care in the ED remains poorly characterized in children. Our objective in this study was to measure the association between body temperature at the physiologic onset of sepsis and the time to initiation of antibiotic treatment and fluid bolus among children with clinically defined sepsis.
Methods:
We conducted a retrospective, cohort study of pediatric patients with sepsis presenting to the ED. Data collected from an existing quality improvement database were supplemented via chart extraction. We assessed body temperature at physiologic onset of sepsis (PO-S), the date and time when a patient first met clinical criteria for sepsis as defined by Goldstein et al. Our primary outcomes were time from PO-S and administration of antibiotics and fluid bolus. Secondary outcomes included maximum vasoactive-inotropic scores, need for extracorporeal membrane oxygenation (ECMO) within 30 days of presentation, presence and type of organ dysfunction, 30-day hospital- and intensive care unit (ICU)-free days, and mortality. We summarized and compared data by temperature group. Multivariable quantile regression was used to evaluate adjusted associations between body temperature and time to initiation of antibiotic treatment and fluid bolus.
Results:
Of 928 patients screened, 385 (41%) met inclusion criteria. Median time to antibiotic treatment did not differ between temperature groups at PO-S-≤ 36.0 °C: median (IQR) 48.5, (41.3-104.8); 36.1-37.9 °C: median, 95.5, (41.3-104.8;), and ≥ 38.0 °C: median 84, 45-151; (P = .24). Median time to fluid bolus administration also did not differ between temperature groups at PO-S-≤ 36.0 °C: median 39, (20.8-65.8); 36.1-37.9 °C: median, 42.5 (21.3-86.3); and ≥ 38.0 °C: median, 54 (29-84); (P =.07). In addition, mortality differed by temperature at PO-S (≤ 36.0 °C: 1/22 (4.5%); 36.1-37.9 °C: 4/80 (5.0%); and ≥. 38.0 °C: 3/283 (1.1%), (P = .04); as did organ dysfunction at 72 hours: ≤. 36.0 °C: 15/22 (68.2%); 36.1-37.9 °C: 43/80 (53.8%), ≥ 38.0 °C: 74/283 (26.1%); (P < .001) and median (IQR) 30-day ICU- and hospital-free days-≤ 36.0 °C: median, 24, (20,-26.8); 36.1-37.9 °C: median, 28 (24.8-30), ≥ 38.0 °C: median, 30 (27-30), (P < .001); and at ≤. 36.0°C: median, 22, (17-25); 36.1-37.9 °C: median, 24 (17.8-27); ≥ 38.0 °C: median, 25 (20, 27), (P = .04), respectively. We did not observe an association between temperature and median time to antibiotic administration (β: 2.5, 95% CI, -4.2 to 9.1, P = .50) or first fluid bolus administration (β: 1.7, 95% CI, -1.4 to 4.8, P = .30).
Conclusion:
Time to fluid bolus administration and time to antibiotic administration did not differ statistically by temperature from physiological onset of sepsis. Children presenting with hypothermia (≤ 36.0 °C) had worse outcomes.
Related Concept Videos
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Pharmacokinetics in Pediatric Patients: Drug Excretion
Assessing Body Temperature - Temporal Artery
Step 1: Perform hand hygiene and don a fresh pair of gloves to prevent cross-infection and ensure patient safety.
Step 2: Explain the procedure to the patient to establish trust. Clear communication establishes trust with the patient, ensures they understand what to expect, promotes cooperation, and enhances comfort during the procedure.
Step 3: Assess the patient's...
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation IV: Pharmacological Management
Drug Dosing: Infants and Children

